Wardwizard Healthcare has issued 6,00,000 fully convertible warrants to Havish Suppliers LLP and Sanjay Kumar Sharma at Rs 10 per warrant. This preferential allotment allows the acquirers to convert these instruments into equity shares within 18 months, representing a 5.40% stake on a fully diluted basis. Investors should note the potential equity dilution as these warrants are exercised.
Wardwizard Healthcare Allots 6 Lakh Convertible Warrants
Wardwizard Healthcare has issued 6,00,000 fully convertible warrants priced at Rs 10 each.
This allotment represents approximately 5.40% of the company's total diluted share capital.
Reader Takeaway: Preferential allotment signals capital infusion but warns shareholders of equity dilution upon future warrant conversion.
What just happened
Wardwizard Healthcare Limited completed a preferential allotment of 6,00,000 fully convertible warrants. The instruments were issued to Havish Suppliers LLP and Sanjay Kumar Sharma. As per the regulatory filing, the company has received 25% of the total consideration upfront, with the remaining 75% due upon the exercise of the conversion rights.
Why this matters
The allotment is a strategic move to raise capital, but it changes the company's capital structure. Each warrant is convertible into one fully paid-up equity share with a face value of Rs 10. Because these warrants are convertible within an 18-month window, the existing equity base will face dilution when the conversion occurs, which may impact earnings per share for current shareholders.
Conversion and Payment Terms
The warrants provide the acquirers flexibility to exercise their conversion rights in one or more tranches over the next 18 months. Since 25% of the payment is settled, the company gains immediate liquidity, while the final conversion will solidify the stake held by the allottees to 5.40% of the total diluted capital.
What to track next
Investors should monitor the company's future filings for announcements regarding the exercise of these warrants. Any decision by the acquirers to convert these instruments will increase the paid-up equity capital, effectively diluting the current shareholders' percentage ownership in the business.
